Amalgamated Bank Grows Position in Agilent Technologies, Inc. (NYSE:A)

Amalgamated Bank raised its position in Agilent Technologies, Inc. (NYSE:A) by 3.1% in the third quarter, Holdings Channel.com reports. The institutional investor owned 61,060 shares of the medical research company’s stock after purchasing an additional 1,862 shares during the period. Amalgamated Bank’s holdings in Agilent Technologies were worth $9,066,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the company. Western Pacific Wealth Management LP boosted its stake in shares of Agilent Technologies by 18.9% during the first quarter. Western Pacific Wealth Management LP now owns 440 shares of the medical research company’s stock worth $64,000 after buying an additional 70 shares during the period. Menard Financial Group LLC grew its stake in shares of Agilent Technologies by 1.6% in the 2nd quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock valued at $628,000 after purchasing an additional 77 shares during the last quarter. McAdam LLC increased its holdings in shares of Agilent Technologies by 3.1% in the third quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock valued at $376,000 after purchasing an additional 77 shares during the period. Global Retirement Partners LLC raised its stake in shares of Agilent Technologies by 3.2% during the third quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock worth $382,000 after purchasing an additional 79 shares during the last quarter. Finally, Marshall Financial Group LLC lifted its holdings in shares of Agilent Technologies by 1.0% during the third quarter. Marshall Financial Group LLC now owns 8,243 shares of the medical research company’s stock worth $1,224,000 after purchasing an additional 82 shares during the period.

Agilent Technologies Trading Up 0.5 %

Shares of A stock opened at $140.41 on Wednesday. The stock has a market cap of $40.34 billion, a P/E ratio of 29.13, a P/E/G ratio of 6.02 and a beta of 1.07. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a fifty-two week low of $104.09 and a fifty-two week high of $155.35. The business has a fifty day simple moving average of $139.70 and a 200-day simple moving average of $138.18.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period last year, the firm posted $1.43 EPS. The firm’s revenue for the quarter was down 5.6% on a year-over-year basis. On average, analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a $0.236 dividend. The ex-dividend date of this dividend was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. Agilent Technologies’s dividend payout ratio (DPR) is 19.50%.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,995 shares of company stock worth $1,739,510 over the last three months.

Analyst Ratings Changes

Several equities analysts have issued reports on A shares. Citigroup boosted their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Evercore ISI increased their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Wells Fargo & Company began coverage on shares of Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective for the company. Stifel Nicolaus reiterated a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a research report on Monday, August 26th. Finally, Barclays raised their price target on Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a report on Tuesday, October 15th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $144.36.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.